The addition of isosorbide dinitrate plus hydralazine to standard therapy significantly increases survival in black patients with advanced heart failure.
Does a fixed dose of isosorbide dinitrate plus hydralazine added to standard therapy increase survival in black patients with advanced heart failure?
The combination of isosorbide dinitrate and hydralazine added to standard therapy increases survival in black patients with advanced heart failure.
Absolute Event Rate: 0% vs 0%
The addition of a fixed dose of isosorbide dinitrate plus hydralazine to standard therapy for heart failure including neurohormonal blockers is efficacious and increases survival among black patients with advanced heart failure.
Taylor et al. (Tue,) reported a other. The addition of isosorbide dinitrate plus hydralazine to standard therapy significantly increases survival in black patients with advanced heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: